High insulin levels are associated with increased breast cancer risk and poor patient survival outcome [17, 48]; therefore, metformin directly and indirectly reduces cancer cell proliferation through reduction of insulin levels and blood glucose levels. This evidence concerns the gene INS and breast carcinoma.